For research use only
| Cat No. | ABC-TC3500 |
| Product Type | Vascular Cells |
| Cell Type | Smooth Muscle Cell |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Aorta |
| Disease | Type II Diabete |
| Storage | Liquid Nitrogen |
Human Aortic Smooth Muscle Cells-Diabetic Type II model diabetic vasculopathy for contractility, inflammation, and atherosclerotic remodeling research.
Human Aortic Smooth Muscle Cells-Diabetic Type II are primary cells isolated from human aortic tissue of clinically confirmed Type II diabetic donors. They are typically obtained and cryopreserved at early passage to maintain their disease-related characteristics. These cells exhibit characteristic spindle-shaped morphology and grow as adherent monolayers. Functionally, they contribute to the regulation of vascular tone, but in a diabetic context, their function is altered. This has been shown to be closely associated with diabetic vasculopathy, a major complication of Type II diabetes. Regarding gene expression, they express smooth muscle-specific proteins like α-smooth muscle actin. These cells have a relatively normal karyotype. Repeated freezing and thawing should be avoided during culture. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.
| Product Code | Human Aortic Smooth Muscle Cells Type II Diabetes, HAoSMCs T2DM, Aortic SMCs Diabetic Type II, Human Aorta Smooth Muscle Cells T2DM, Diabetic Type II Aortic SMCs |
| Species | Human |
| Cat.No | ABC-TC3500 |
| Product Category | Primary Cells |
| Size/Quantity | 1 vial |
| Cell Type | Smooth Muscle Cell |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Aorta |
| Disease | Type II Diabete |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Vascular Cells |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
Human Aortic Smooth Muscle Cells-Diabetic Type II can be utilized as an in vitro cell model to investigate the pathophysiology of diabetic vasculopathy. Researchers can utilize this system to investigate altered signaling pathways related to vascular tone regulation, examine pathological extracellular matrix (ECM) remodeling processes, and elucidate molecular mechanisms underlying diabetic aortic damage. The cells are particularly useful for screening potential therapeutic strategies, identifying novel drug targets, and developing interventions to mitigate the progression of diabetic-related aortic damage.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).